CYCN
Cyclerion Therapeutics
Stock NASDAQ – Stock Market Prices, News & Analysis
Cyclerion Therapeutics Inc est une entreprise biopharmaceutique se concentrant sur le développement de médicaments pour le traitement de maladies rares et graves.
Cyclerion Therapeutics
CYCN
Cyclerion Therapeutics Inc est une entreprise biopharmaceutique se concentrant sur le développement de médicaments pour le traitement de maladies rares et graves.
Price history of Cyclerion Therapeutics
Price history of Cyclerion Therapeutics
Performance & Momentum
Cyclerion accelerates clinical development for resistant depression
Cyclerion Therapeutics (NASDAQ: CYCN) announced a strategic partnership with Medsteer to enhance its closed-loop anesthesia platform and reported progress toward launching a Phase 2 trial for its CYC-126 treatment targeting treatment-resistant depression. This milestone, expected in the second half of 2026, aligns with Cyclerion's strategy to reestablish itself as a neuropsychiatric company, supported by a licensing agreement with MIT. These developments are poised to improve the company's growth prospects and could boost investor confidence.
Similar stocks to Cyclerion Therapeutics
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
